Vita Genomics Inc (賽亞基因科技), Taiwan’s largest genomics-based biotechnological and biopharmaceutical company, is in talks with potential buyers eyeing the company’s unique business model, a senior company executive said.
The development came after the New Taipei-based company announced plans to forge partnerships between testing facilities and hospitals aimed at growing mutual clientele and profits, Vita Genomics general manager Eddy Hsieh (謝春成) said.
Hsieh joined Vita Genomics in October 2013 when it was in the red and saw the company into profit last year.
Hsieh said he plans to build Vita Genomics into the healthcare industry’s “7-Eleven,” — the nation’s largest convenience store chain with more than 3,000 outlets.
“Some Taiwanese firms approached us with a view to acquiring Vita Genomics, attracted by its business potential,” Hsieh said.
He refused to name the interested parties for fear of sinking the deals prematurely except to say that they are in the technology sector.
Under Hsieh’s leadership, Vita Genomics is seeking the integration of the companies in its supply chain, including genomics testing facilities, pathology-testing laboratories and clinics.
There are more than 8,000 clinics in the nation and Vita Genomics aims to enter an alliance with at least 5,000 of them in the next three years, allowing them to overcome their inability to perform tests, Hsieh said.
That would give the company the top position in the industry with a 50 percent market share, he said, adding there are no competitors on the horizon.
However, integration is not an easy process, as many clinics prefer to maintain the “status quo,” Hsieh said, adding that like traditional grocery stores, they will be forced out of the market, if they reject strategic alliances.
The company would agree to acquisition bids that might help accelerate the integration, Hsieh said.
Vita Genomics has a market value of NT$3.2 billion (US$101.32 million) after the company booked NT$103 million in net income last year, or NT$2.37 per share, Hsieh said.
The company is in the process of increasing its capital by NT$800 million — from NT$460 million — and it is slated to list on the Emerging Stock Market in June and trade shares on the over-the-counter GRETAI Securities Market next year, Hsieh said.
“The capital increase is virtually completed as venture capital funds at home and overseas have lent their support,” Hsieh said.
China Development Financial Holding Corp (中華開發金控), Transglobe Life Insurance Co (全球人壽) and government-owned National Development Fund (國發基金) have contributed to the boost in capital, Hsieh said.
RECORD BUDGET: TSMC does plan to raise its proposed capital expenditure a lot, and could benefit if Intel outsources more of its production to foundries, analysts said Intel Corp’s earnings conference call on Thursday is expected to clarify the US semiconductor giant’s outsourcing production plans, which would be crucial regarding Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) performance, analysts said. “TSMC stands to benefit if Intel outsources more of its fabrication to foundries,” SinoPac Securities Investment Service Corp (永豐投顧) analysts said in a note on Friday. Yuanta Securities Investment Consulting Co (元大投顧) was more cautious, saying that Intel’s contribution initially would be limited, but its outsourcing plans would still highlight TSMC’s leadership in technology, it added. “Intel will continue to manufacture server or high-end central processing units [CPUs], which have higher
MOBILE SMART: The Dimensity 1200 is 22 percent better in terms of performance than its predecessor, and 25 percent more power-efficient, the handset chip designer said MediaTek Inc (聯發科) yesterday unveiled its premium 5G processors — the Dimensity 1200 and Dimensity 1100 — as it vies for a larger slice of the world’s rapidly growing 5G smartphone market. Manufactured using Taiwan Semiconductor Manufacturing Co’s (台積電) 6-nanometer process technology, the Dimensity 1200 processor performs 22 percent better than the previous generation Dimensity 1000+ processor, and is 25 percent more power-efficient, MediaTek said. Chinese smartphone brands Xiaomi Corp (小米) and Realme Mobile Telecommunications (Shenzhen) Co (銳爾覓移動通信) are to be the first adopters of the latest Dimensity chips, the companies said during a virtual media briefing. Xiaomi plans to equip its first
‘BROAD RANGE’: The US Department of Commerce intends to deny a significant number of license requests for exports to Huawei, an industry association said US President Donald Trump’s administration notified Huawei Technologies Co (華為) suppliers, including chipmaker Intel Corp, that it is revoking certain licenses to sell to the Chinese company and intends to reject dozens of other applications to supply the telecommunications firm, people familiar with the matter told reporters. The action — likely the last against Huawei under Trump — is the latest in a long-running effort to weaken the world’s largest telecommunications equipment maker, which Washington sees as a national security threat. The notices came amid a flurry of US efforts against China in the final days of Trump’s administration. US president-elect Joe
From India to China to the US, automakers cannot make vehicles — not that no one wants any, but because a more than US$450 billion industry for semiconductors got blindsided. How did both sides end up here? Over the past two weeks, automakers across the world have bemoaned the shortage of chips. Germany’s Audi, owned by Volkswagen AG, would delay making some of its high-end vehicles because of what chief executive officer Markus Duesmann called a “massive” shortfall in an interview with the Financial Times. The firm has furloughed more than 10,000 workers and reined in production. That is a further blow